We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
We are consulting on a set of proposals to improve and strengthen the UK clinical trials legislation to help us make the UK the best place to research and develop safe and innovative medicines
1. Executive summary The Medicines and Medical Devices Act 2021 provides…
The Medicines and Medical Devices Act 2021 (‘the Act’) received Royal…
How to respond The Government invites responses on the specific questions…
Public consultation on proposals to allow pharmacists to dispense prescription medicines in original packaging, in particular those containing sodium valproate.
Background Regulation 214(1) contained in part 12 of the Human Medicines…
The aim of this consultation is to seek the views of stakeholders on proposals for changes to the Medicines and Healthcare products Regulatory Agency’s statutory fees.
Background Generally, wherever the MHRA provides a direct service for…
The MHRA is proposing to prepare secondary legislation to implement the…
Question 1 Do you support proposal 1, to apply a 10% indexation uplift…
Agency fees review overview Aim The aim of the fees review was to make…
Proposed statutory fees from 1 April 2023 Table 1 – 10% Indexation…
The Medicines and Medical Devices Act 2021 (the Act) received Royal Assent…
How to respond Responses are invited on the specific questions raised. The…
Information published in response to this consultation, including personal…
We’d value your views to help shape the introduction of a new regulatory framework for products supplied at the point of care.
The MHRA is reviewing its approach to engagement with healthcare professionals to improve the safety of medicines and medical devices.
We are consulting on a set of proposals to improve and strengthen the Code of Practice for experts who provide advice on which decisions about the regulation of medicines and medical devices are based, to ensure that experts…
Public consultation on a set of proposals to make Gina 10 microgram vaginal tablets (Estradiol) available from pharmacies.
We're looking for your views on how medical devices will be regulated across the United Kingdom (UK) in the future.
Public consultation on a set of proposals to make Aquiette 2.5mg Tablets (oxybutynin hydrochloride) available from pharmacies
We're looking for your views and comments on our proposed legislative changes to clarify the legal basis for EAMS.
We want your comments on the clarity and wording of our new guidance
Seeks views on proposed changes to the Human Medicines Regulations and the Medicines Act.
A 3-week public consultation on a proposal to make Hana 75 microgram film-coated tablets (Desogestrel) available from pharmacies.
A 3-week consultation on a proposal to make Lovima 75 microgram film-coated tablets (Desogestrel) available from pharmacies.
We’re looking for views from patients and the public on how we engage with them.
The MHRA is asking for views on a proposal to make Nuromol Dual Action Pain Relief 200mg/500mg tablets (ibuprofen/paracetamol) available without prescription in general sales outlets, such a supermarkets.
Call for information to support a review of isotretinoin, a treatment for severe acne. This review is being undertaken by the Medicines and Healthcare products Regulatory Agency with advice from the Commission on Human Medic…
This consultation asks for views on the application of AQbD principles to pharmacopoeial standards for medicinal products.
Work is ongoing to address the comments and feedback from respondents to the consultation. Publication of our report on the consultation has been delayed in light of the Agency’s response during the ongoing coronavirus situa…
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.